Rechercher | Webyourself Social Media Platform

Sneha CMI Ajout d’un nouvel article Autre
2024-06-13 13:17:20 -

Advances in Neurodegenerative Disease Treatments
Our understanding of the complex biological mechanisms involved in neurodegenerative diseases like Alzheimer’s and Parkinson’s diseases has increased tremendously in recent years. Researchers have gained new insights into the role that proteins like beta-amyloid and tau play in the development and progression of Alzheimer’s disease. For Parkinson’s disease, abnormal...

0 Commentaires 0 Parts 587 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Rushikesh Chavan Ajout d’un nouvel article Health
2024-10-11 08:14:39 -

Comprehensive Analysis of the Global Neurodegenerative Disease Market
The Global Neurodegenerative Disease Market Size is Anticipated to Exceed USD 90.10 Billion by 2033, Growing at a CAGR of 7.84% from 2023 to 2033. The Global Neurodegenerative Disease Market is undergoing significant growth, with projections indicating that it will exceed USD 90.10 billion by 2033. This growth is anticipated at a CAGR of 7.84% from 2023 to 2033,...

0 Commentaires 0 Parts 219 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Snehal Biraje Ajout d’un nouvel article Autre
2024-06-21 06:36:05 -

Neurodegenerative Disease Market Size, Share, Trends, Opportunities, Key Drivers and Growth Prospectus
The global Neurodegenerative Disease market size reached USD 52.03 billion in 2023. Looking forward, Analytica Global expects the market to reach USD 102.6 billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. Analytica Global Research newly added a research report on the Global Neurodegenerative Disease Market, which represents a study for the period from 2024 to...

0 Commentaires 0 Parts 652 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Aavika Shinde Ajout d’un nouvel article Autre
2024-11-14 07:29:19 -

Olivopontocerebellar Atrophy (OPCA) Market Expands with Advancements in Neurodegenerative Disease Research
"Olivopontocerebellar Atrophy (OPCA) Market Size And Forecast by 2031 Global Olivopontocerebellar Atrophy (OPCA) market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR of 4.20% in the above-mentioned research forecast period. Olivopontocerebellar Atrophy (OPCA) Market research report...

0 Commentaires 0 Parts 51 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Sayli Bujone Ajout d’un nouvel article Health
2024-07-15 09:02:17 -

Patient-Centric Approaches: Shaping the Future of Neurodegenerative Disease Market
The report presents detailed information regarding the prominent players and potential competitors in the Neurodegenerative Disease Market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives. Additionally, the report analyses revenue share and contact details for each player.This...

0 Commentaires 0 Parts 514 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Ashwini Bakhade Ajout d’un nouvel article Autre
2024-10-16 10:03:20 -

Friedreich's Ataxia: Unraveling the Mysteries of an Inherited Neurodegenerative Condition A Fresh Perspective
What is Friedreich's Ataxia? FDRA (FA) is an inherited neurodegenerative disorder that causes progressive loss of coordination and balance. It affects the nerve cells in the brain and spinal cord. The most common early symptoms are problems with walking and balance that slowly worsen over time. FA is typically diagnosed in childhood or early adulthood. Friedreich's Ataxia is an autosomal...

0 Commentaires 0 Parts 217 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Pooja Salve Ajout d’un nouvel article Health
2023-09-26 12:43:11 -

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Is Estimated To Witness High Growth Owing To Rising Prevalence of ALS & Increasing R&D Investments
The Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market is estimated to be valued at US$662.3 million in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period from 2023 to 2030, according to a new report published by Coherent Market Insights.Market Overview:The Amyotrophic Lateral Sclerosis (ALS) Treatment Market deals with the development and commercialization of...

0 Commentaires 0 Parts 1961 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Pooja Salve Ajout d’un nouvel article Health
2023-09-26 12:43:31 -

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Is Estimated To Witness High Growth Owing To Rising Prevalence of ALS & Increasing R&D Investments
The Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market is estimated to be valued at US$662.3 million in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period from 2023 to 2030, according to a new report published by Coherent Market Insights.Market Overview:The Amyotrophic Lateral Sclerosis (ALS) Treatment Market deals with the development and commercialization of...

0 Commentaires 0 Parts 1867 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Raj Kumar Dhote Ajout d’un nouvel article Health
2024-08-12 11:48:54 -

Multiple Sclerosis Therapeutics: Recent Advances in Therapeutics for Multiple Sclerosis
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system that damages myelin, the protective sheath surrounding nerve fibers of the brain, spinal cord, and optic nerves. This damage disrupts communication between the brain and other parts of the body. MS destroys myelin and the myelin-forming cells (oligodendrocytes) and in some cases also attacks the axons...

0 Commentaires 0 Parts 447 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Ashwini Bakhade Ajout d’un nouvel article Autre
2024-06-04 10:58:50 -

The Global Memantine Market Growth Is driven by rising prevalence of Alzheimer's disease
The memantine market overview involves neuroprotective properties of memantine for treatment of moderate to severe forms of Alzheimer's disease. Memantine is an NMDA receptor antagonist approved as an add-on therapy to cholinesterase inhibitors for patients with moderate to severe Alzheimer's disease. It regulates glutamate activity to inhibit neurotoxicity and protect neurons from...

0 Commentaires 0 Parts 741 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!

Plus de résultats